BACKGROUND: Incidence of biliary tract cancers (BTCs) in China is high, and surgery is the only curative option. Preoperative CA19-9 has been identified as a predictor for survival in patients with resectable BTCs, but more potential predictors need to be studied. This retrospective study aimed to establish the prognostic significance of CA19-9/TBIL ratio (CTR) in patients with BTCs. METHODS: A retrospective analysis was performed in patients who were diagnosed with BTCs and received surgical resection between 2013 and 2018 at PUMCH. Demographic and clinical parameters were collected. Preoperative CA19-9 and CTR were classified as elevated (>58.6 and >0.83) according to the receiver operating characteristic (ROC) analysis. Demographic and clinical parameters were compared between the groups using Student's t-test, chi-square, or Fisher's exact test. Survival analysis was performed by the Kaplan-Meier methods, and the relationship between variables and survival was assessed by the log-rank test. Cox regression analysis was conducted to identify potential risk factors for overall survival. RESULTS: In total, 109 participants were involved in the final analysis. The overall survival rate was 18.0% at 5 years, with a median survival duration of 1.58 years. The Kaplan-Meier analysis indicated that higher CTR was associated with shorter OS (15 vs. 50, p < 0.01). Univariate survival analysis identified TNM staging, CA19-9, and CTR as statistically significant prognostic factors. In a multiple Cox analysis, only CTR was proved as a significantly independent prognostic factor. CONCLUSION: CTR acts as an independent prognostic predictor for patients with biliary tract cancer.
BACKGROUND: Incidence of biliary tract cancers (BTCs) in China is high, and surgery is the only curative option. Preoperative CA19-9 has been identified as a predictor for survival in patients with resectable BTCs, but more potential predictors need to be studied. This retrospective study aimed to establish the prognostic significance of CA19-9/TBIL ratio (CTR) in patients with BTCs. METHODS: A retrospective analysis was performed in patients who were diagnosed with BTCs and received surgical resection between 2013 and 2018 at PUMCH. Demographic and clinical parameters were collected. Preoperative CA19-9 and CTR were classified as elevated (>58.6 and >0.83) according to the receiver operating characteristic (ROC) analysis. Demographic and clinical parameters were compared between the groups using Student's t-test, chi-square, or Fisher's exact test. Survival analysis was performed by the Kaplan-Meier methods, and the relationship between variables and survival was assessed by the log-rank test. Cox regression analysis was conducted to identify potential risk factors for overall survival. RESULTS: In total, 109 participants were involved in the final analysis. The overall survival rate was 18.0% at 5 years, with a median survival duration of 1.58 years. The Kaplan-Meier analysis indicated that higher CTR was associated with shorter OS (15 vs. 50, p < 0.01). Univariate survival analysis identified TNM staging, CA19-9, and CTR as statistically significant prognostic factors. In a multiple Cox analysis, only CTR was proved as a significantly independent prognostic factor. CONCLUSION: CTR acts as an independent prognostic predictor for patients with biliary tract cancer.
Authors: Chang Moo Kang; Jun Young Kim; Gi Hong Choi; Kyung Sik Kim; Jin Sub Choi; Woo Jung Lee; Byong Ro Kim Journal: J Surg Res Date: 2007-04-09 Impact factor: 2.192
Authors: Mie Grunnet; Ib J Christensen; Ulrik Lassen; Lars H Jensen; Magnus Lydolph; Jennifer J Knox; Mairead G McNamara; Mark Jitlal; Harpreet Wasan; John Bridgewater; Juan W Valle; Morten Mau-Sorensen Journal: Eur J Cancer Date: 2015-05-09 Impact factor: 9.162
Authors: Ioannis Hatzaras; Carl Schmidt; Peter Muscarella; W Scott Melvin; E Christopher Ellison; Mark Bloomston Journal: HPB (Oxford) Date: 2010-03 Impact factor: 3.647
Authors: J L Humphris; D K Chang; A L Johns; C J Scarlett; M Pajic; M D Jones; E K Colvin; A Nagrial; V T Chin; L A Chantrill; J S Samra; A J Gill; J G Kench; N D Merrett; A Das; E A Musgrove; R L Sutherland; A V Biankin Journal: Ann Oncol Date: 2012-01-11 Impact factor: 32.976
Authors: Jonathan G Navarro; Jin Ho Lee; Incheon Kang; Seoung Yoon Rho; Gi Hong Choi; Dai Hoon Han; Kyung Sik Kim; Jin Sub Choi Journal: HPB (Oxford) Date: 2020-02-08 Impact factor: 3.647